Vanda Pharmaceuticals

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$3.29-$6.75
Market Cap
$268.1M
Shares Short
3M

Financials

See more
Revenue (12 Mos)
$182M
Revenue Growth (YoY)
9.6%
Gross Profit (12 Mos)
$230.1M
Diluted EPS
-$0.19

News

See more

Yahoo Finance • 8 months ago

Vanda Pharmaceuticals announces the publication of an article on "The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial" in the Clinical Gastroenterology and Hepatology Journal

Yahoo Finance • 11 months ago

Vanda Pharmaceuticals Reports Third Quarter 2023 Financial Results

Yahoo Finance • last year

Q1 2023 Vanda Pharmaceuticals Inc Earnings Call

Yahoo Finance • 2 years ago

VANDA PHARMACEUTICALS ANNOUNCES NOTICE OF OPPORTUNITY FOR AN FDA HEARING ON THE sNDA FOR HETLIOZ® IN JET LAG DISORDER

About

CEO
Dr. Mihael H. Polymeropoulos M.D.
CFO
Mr. Kevin Patrick Moran
Address
2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
203